Biotech China 2014

Biology: Pfizer

Total Score People Score Events Score
51 45 35
Date Event Presentation Speakers
May 23, 2014 (E2) Keystone Symposia: Autophagy: Fundamentals to Disease Pharmacological Manipulation of Autophagy Registered attendees can view abstracts starting on 04/23/2014 Christina H. Eng
March 19, 2014 3rd Neurological Biomarkers Coalition Against Major Diseases (CAMD): Regulatory Science Accelerates Drug Development and Biomarkers for Neurodegenerative Diseases Diane Stephenson
June 3, 2013 Asia Biotech Invest 2013 Commercialising innovation – Biotech business models for future growth Yuan-Hua Ding
March 19, 2013 Discovery Chemistry Congress The Future of Formulation and Drug Delivery in Global Healthcare Provision Sven Stegemann
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Plenary: Transforming Drug Discovery for Complex Diseases: A Systems Biology Approac Piet Van Der Graaf
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Career-Development Lunch Sessions David A. Roth
December 4, 2012 4th World Epigenetics Summit Epigenetic Protein Families: A New Frontier in Small Molecule Drug Discoverys Paul Fish
December 9, 2011 2nd Oxford Symposium on Epigenetic Mechanisms in Health and Disease Sessions 4 | Novel Small molecule Inhibitors of KMT7, A Lysine Mono-Methyltransferase Caroline Benn
July 28, 2011 International Conference on Biomedical Ontology Developing a Reagent Application Ontology within the OBO Foundry Framework Christopher L. Shaffer
November 3, 2010 Eighth Annual RNAi for Functional Screens Translating Human Genetic Discoveries to Novel Targets and Therapeutics Albert B. Seymour
An Image-based siRNA Screen for Kinase Genes That are Important for Cancer Cells to Adapt to Hypoxia Steven Haney
Chairperson’s Remarks Albert B. Seymour
PANEL DISCUSSION: The Current Fate of Drug Targets Being Uncovered by RNAi Screens Albert B. Seymour
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit China's Pharmaceutical Industry from the Insiders' Eyes Steve Yang
Chairperson's Opening Remarks Steve Yang
4 Simultaneous Global Development - What Does It Mean for China? Bradley Merchant
An MNC's Perspective on the Overall Capabilities of China's Biosimilars/FOB Development - A Comparison with US/EU Yining Zhao
Martin Mackay, Ph.D. Right Targets. Right Patients. Right Now. Martin Mackay
November 6, 2009 Clinical Applications for Age Management Medicine Continental Breakfast Erik Kuja
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery Session chair: Carolyn Cho
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Human Genetics and Disease Relevant Targets: Linking Clinical Outcomes to Targets Albert B. Seymour
RNAi in Practice Ð Assays and Screening in Mammalian Cells Steven Haney
Tissue Engineered Tumor Niches as Drug Testing Platforms Eric YH Park
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Imaging Techniques for Assessing Toxicity in Primary Human Hepatocytes Eric Tien
Imaging for Hepatotoxicity Eric Tien
Drug-Induced Mitochondrial Dysfunction Yvonne Will
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety In Vitro - In Vivo Correlations of Drug-Induced Liver Injury Jinghai Xu
Strategies to Reduce NCE Hepatotoxicity Attrition Due to Mitochondrial Toxicity- Designing Novel Screening Methods Sashi Nadanaciva
June 9, 2009 RNAi for Target Identification and Validation I. Surveying RNAi Opportunities: From Tools to Therapies Arthur M. Krieg
Chairperson’s Remarks Albert B. Seymour
Human Genetic Approaches to Target Discovery and Validation: Starting With the Clinical Endpoint of Interest Albert B. Seymour
June 4, 2009 Structure-Based Drug Design Using Thermodynamic Information to Enhance Quality of Design in Lead Generation Andrew D. Scott
Thinking Out Loud, a Day One Closing Panel: Are we ready for a GPCR structural explosion? Tomi Sawyer
Improving the Quality of Structure-Based Virtual Screen by The Interaction-Focused Post-Docking Analysis Suo-Bao Rong, Brian S. Bronk
Chairperson’s Remarks Tomi Sawyer
February 11, 2009 4th annual Bioanalysis in Clinical Research Panel discussion: Coming to a consensus on evaluating the level of agreement between original and repeated results Hendrik Neubert
February 9, 2009 Immunogenicity for Biologics 2009 Neutralising antibody assays: Competitive ligand binding assays vs. bioassays Deborah Finco Kent
January 26, 2009 7th Annual Partnering with Central Labs B2 : Personalized Medicine and Its Impact on Drug development and Commercialization David Lester
Technical Hot Topics David Lester
Track B : Utility of Imaging in Clinical Trials- Strategies for Success Craig Lipset
Track B : Metrics Champion Consortium Imaging Performance Metrics Announcement Craig Lipset
December 7, 2008 Antibody Engineering Technology Workshops : Using the ProteOn to Characterize Antigen/Antibody Interactions Yasmina Abdiche
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Title: TBD :Track 2-3 Yuan-Hua Ding
September 16, 2008 Structural Biology and Activation Mechanisms of Membrane Receptors (S1) Evolution of the Insulin/IGF Receptor Systems Robert S Garofalo
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Afternoon Symposia 4: Signal Transduction Networks as Molecular Machines: Implications for Drug Discovery Preston Hensley
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Exploring Chemical Space in Protein-Protein Inhibitor Drug Discovery Tomi Sawyer
January 6, 2008 Structural Genomics and its Applications to Chemistry, Biology and Medicine Workshop 1: Applications of Structural Genomics for Structural Biology David C. Wood
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 16: Protein and Peptide Drug Development (13:30-17:00) Anton Fliri, Xing Wang
Session 16: Studies on the Origin of Protein Network Topologies (14:50-15:10) Anton Fliri
Session 16: Analytical Challenges in Protein Therapeutics Development (13:30-13:50) Xing Wang
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) Keynote Session: Executive Panel: Delivering Drugs for Difficult Targets(08:40-09:40) Alexander Rod MacKenzie
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) Keynote Introduction; Executive Panel: Delivering Drugs for Difficult Targets (08:40-09:40) Alexander Rod MacKenzie
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SELECTING LEADS AND DETECTING ADVERSE ACTIVITY (14:00-17:30) William T. Loging
SELECTING LEADS AND DETECTING ADVERSE ACTIVITY: Analysis of Drug Induced Effect Patterns for Investigating Systems Structure Effect Relationships (14:35-15:05) William T. Loging
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) OVERVIEW SESSION (12:00-15:15) Donald E. Frail
OVERVIEW SESSION: Integration of “Indications Discovery” Efforts within Pfizer (14:15-14:45) Donald E. Frail
REPROFILING DRUGS (08:30-13:30) Donald E. Frail
REPROFILING DRUGS: Panel Discussion - IP and Practical Issues of Drug Repositioning and Repurposing (11:15-12:00) Donald E. Frail
September 27, 2007 Protein Expression Europe (Sep 27-28) Parallel Approaches Continued (09:00-11:40) Ciaran Cronin
Parallel Approaches Continued: A Model for Parallel Protein Production (10:40-11:10) Ciaran Cronin
Drug Discovery Applications (13:00-15:15) Stephen Irving
Drug Discovery Applications: Overcoming Challenges in Supplying Proteins for Structural Biology (14:15-14:45) Stephen Irving
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third Annual Toxicity Biomarkers; TOXICITY BIOMARKER DISCOVERY (08:30-11:00) Frances Clemo
Third Annual Toxicity Biomarkers; TOXICITY BIOMARKER DISCOVERY: Preclinical Biomarkers of Hepatotoxicity: What’s new? (09:35-10:05) Frances Clemo
Pre-Conference Workshops; Biomarker Assay Development and Validation: Part I Tutorial FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION (08:00-12:00) Jean W Lee
September 10, 2007 Drug Development In China: Strategies for launching Discovery and Development activities OPENING KEYNOTES: R&D Strategic Sourcing in China: A Dynamic View (11:00 - 11:45) Steve Q. Yang
OPENING KEYNOTES (09:00 - 11:45) Steve Q. Yang
OPENING KEYNOTES: Interactive Panel Discussion #1 (11:45 - 12:30) Steve Q. Yang
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.